Publication | Closed Access

In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation

Molecular DockingCombinatorial ChemistryMedicinal ChemistryGlycogen SynthaseBiochemistryMedicineDrug DiscoveryNatural SciencesSilico Design NovelRational Drug DesignPharmacologyMolecular Design